Study to Investigate the Use of Acalabrutinib in the Treatment of Patients With Chronic Lymphocytic Leukemia
Clinical trial NCT04178798 · COMPLETED
Trial details
- NCT number
- NCT04178798
- Sponsor
- PETHEMA Foundation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-09
- Primary completion
- 2024-12-03
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.